The Clinician's Guide to ACE Inhibition
John G.F. Cleland(Author)
Churchill Livingstone (Publisher)
Published on 31. March 1993
Book
Hardback
244 pages
978-0-443-04855-5 (ISBN)
Description
This is a short handbook laying down practical advice and guidelines in an easily assimilable form designed to help clinicians make decisions about prescribing ACE inhibitors. The book focuses on the use of ACE inhibitors in heart failure but also covers hypertension in some detail. Summaries of key points are included.
This is a short handbook laying down practical advice and guidelines in an easily assimilable form designed to help clinicians make decisions about prescribing ACE inhibitors. The book focuses on the use of ACE inhibitors in heart failure but also covers hypertension in some detail. Summaries of key points are included.
This is a short handbook laying down practical advice and guidelines in an easily assimilable form designed to help clinicians make decisions about prescribing ACE inhibitors. The book focuses on the use of ACE inhibitors in heart failure but also covers hypertension in some detail. Summaries of key points are included.
More details
Language
English
Place of publication
London
United Kingdom
Publishing group
Elsevier Health Sciences
Target group
College/higher education
Professional and scholarly
Illustrations
20 line drawings, 10 half-tones, charts, graphs, index
Dimensions
Height: 20 mm
Width: 223 mm
Weight
444 gr
ISBN-13
978-0-443-04855-5 (9780443048555)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Classification
Other editions
Previous edition
John G.F. Cleland
The Clinician's Guide to Ace Inhibition
Book
01/1993
Churchill Livingstone
€8.07
Article exhausted; check for reprint
Content
Basic mode of action in heart failure; basic mode of action in hypertension; neuroendocrine activation in left ventricular dysfunction and heart failure; the effects of ACE inhibitors in resting haemodynamics; the effects of ACE inhibitors on exercise; the effect of ACE inhibitors on renal function; the metabolic consequences of ACE inhibition; the use of ACE inhibitors after myocardial infarction; an overview of survival studies in left ventricular dysfunction; ACE inhibitors and coexisting disease; drug interactions with ACE inhibitors; comparison between ACE inhibitors and other therapies for heart failure and hypertension, and comparison between ACE inhibitor drugs; safety and tolerance and practical aspects of prescribing.